GSK Investigational Site

Providence, Rhode Island 02903

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Neoplasms Clinical Trial
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Providence, RI
Click here to add this to my saved trials